Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer
Study Number: 

I 225612

Phase: 
II
Trial categories: 
Lung
Small Cell Lung Cancer (SCLC)
Principal Investigator: